9 completed, 1 unknown. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Teratogenesis: new trials by email Literature Review of Teratogenesis trials Research Report on Teratogenesis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Biomarkers of Neurological Disease in Utero Study Epilepsy, Neurodevelopmental Disorders | Unknown | Nottingham University Hospitals NHS Trust | 20 | 2019-06-01 | 2020-10-08 | |
| Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) Revlimid - Lymphoma | Completed | Celgene | 1149 | 2017-05-30 | 2025-03-30 | |
| A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg Multiple Myeloma | Completed | Celgene | 1149 | 2015-04-30 | 2022-07-05 | |
| Increasing Contraception Utilization Among Women Prescribed Teratogenic Medications Education - Teratogenesis | Not applicable | Completed | University of California, San Diego | 33 | 2012-01-05 | 2019-10-09 |
| A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use Multiple Myeloma | Completed | Celgene | 361 | 2011-02-18 | 2022-06-14 | |
| A Study of Special Use Results Surveillance of Revlimid 5mg Capsules Multiple Myeloma, Myelodysplastic Syndromes | Completed | Celgene | 4626 | 2010-07-20 | 2022-06-14 | |
| Valnoctamide in Mania valnoctamide - Mania, Schizoaffective Disorder, Manic Type | Phase 3 | Completed | Beersheva Mental Health Center | 80 | 2004-09-01 | 2009-11-25 |
| Twinrix Pregnancy Registry Data Collection - Hepatitis | Completed | GlaxoSmithKline | 245 | 2001-05-18 | 2019-02-04 | |
| Maternal Lipids and Offspring Adiposity at 5-7 Years Adiposity | Completed | Belfast Health and Social Care Trust | 1224 | 2001-01-09 | 2017-10-23 | |
| The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases Basal Cell Carcinoma, Keratosis Palmaris et Plantaris | Completed | National Cancer Institute (NCI) | 130 | 1977-10-01 | 2008-03-04 |
Arrhythmias, Cardiac (4) · Heart Failure (4) · Hypersensitivity (4) · Infections (4) · Lung Diseases, Interstitial (4) · Peripheral Nervous System Diseases (4) · Tumor Lysis Syndrome (4) · Hemorrhage (3) · Multiple Myeloma (3) · Renal Insufficiency (3) · Confusion (2) · Constipation (2) · Diarrhea (2) · Dizziness (2)
Pathologic Processes (10) · Pathological Conditions, Signs and Symptoms (10) · Nervous System Diseases (6) · Signs and Symptoms (6) · Female Urogenital Diseases and Pregnancy Complications (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Urogenital Diseases (5) · Cardiovascular Diseases (4) · Embolism and Thrombosis (4) · Female Urogenital Diseases (4) · Heart Diseases (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (4)
Data Collection (1) · Educational Status (1) · Lenalidomide (1) · valnoctamide (1)
Celgene (4) · Beersheva Mental Health Center (1) · Belfast Health and Social Care Trust (1) · GlaxoSmithKline (1) · National Cancer Institute (NCI) (1) · Nottingham University Hospitals NHS Trust (1) · University of California, San Diego (1)
Japan (4) · United States (3) · Israel (1) · United Kingdom (1)
David R McCance, MD (1) · Jinshu Cho (1) · RH Belmaker, MD (1) · Sheila Mody, MD MPH (1) · Tayyib T Hayat, MRCP PhD (1)
R01HD034242 (1)